Radiographic progression and clinical status are differentially related for adalimumab plus methotrexate (MTX) vs. monotherapy with adalimumab or MTX: Subanalysis of premier Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology Emery, P., Genovese, M., van Vollenhoven, R., Patra, K., Sasso, E. OXFORD UNIV PRESS. 2008: II115–II116

View details for Web of Science ID 000254680900399